Evidence map›Paper›PMID 18464893›Full record

ArticlePLoS pathogens2008

Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection.

Smita Srivastava, Selene K Swanson, Nicolas Manel, Laurence Florens, Michael P Washburn, Jacek Skowronski

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 204 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Smita SrivastavaCold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America.
Selene K Swanson
Nicolas Manel
Laurence Florens
Michael P Washburn
Jacek Skowronski
Stowers Institute for Medical Research · USCold Spring Harbor Laboratory · US

Funding

MOLECULAR INTERACTIONS OF NEF AND AIDS PATHOGENESISR01AI042561 · NIAID · COLD SPRING HARBOR LABORATORY · PI SKOWRONSKI, JACEK · 1998 to 2007
$4.7M
CELLULAR FACTORS REQUIRED FOR HIV ENTRYR37AI033303 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LITTMAN, DAN · 1998 to 2007
$3.3M
MOLECULAR BIOLOGY OF LENTIVIRAL VPR AND VPX PROTEINSR01AI077459 · NIAID · COLD SPRING HARBOR LABORATORY · PI SKOWRONSKI, JACEK · 2008 to 2012
$2.0M
CELLULAR FACTORS REQUIRED FOR HIV ENTRYR01AI033303 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LITTMAN, DAN R · 1993 to 1997
–
NIAID NIH HHS AI-033303NIAID NIH HHS AI-42561NIAID NIH HHS AI-77459NIAID NIH HHS R01 AI042561NIAID NIH HHS R01 AI077459NIAID NIH HHS R37 AI033303
6 · The paper itself

Abstract

Vpx is a small virion-associated adaptor protein encoded by viruses of the HIV-2/SIVsm lineage of primate lentiviruses that enables these viruses to transduce monocyte-derived cells. This probably reflects the ability of Vpx to overcome an as yet uncharacterized block to an early event in the virus life cycle in these cells, but the underlying mechanism has remained elusive. Using biochemical and proteomic approaches, we have found that Vpx protein of the pathogenic SIVmac 239 strain associates with a ternary protein complex comprising DDB1 and VprBP subunits of Cullin 4-based E3 ubiquitin ligase, and DDA1, which has been implicated in the regulation of E3 catalytic activity, and that Vpx participates in the Cullin 4 E3 complex comprising VprBP. We further demonstrate that the ability of SIVmac as well as HIV-2 Vpx to interact with VprBP and its associated Cullin 4 complex is required for efficient reverse transcription of SIVmac RNA genome in primary macrophages. Strikingly, macrophages in which VprBP levels are depleted by RNA interference resist SIVmac infection. Thus, our observations reveal that Vpx interacts with both catalytic and regulatory components of the ubiquitin proteasome system and demonstrate that these interactions are critical for Vpx ability to enable efficient SIVmac replication in primary macrophages. Furthermore, they identify VprBP/DCAF1 substrate receptor for Cullin 4 E3 ubiquitin ligase and its associated protein complex as immediate downstream effector of Vpx for this function. Together, our findings suggest a model in which Vpx usurps VprBP-associated Cullin 4 ubiquitin ligase to enable efficient reverse transcription and thereby overcome a block to lentivirus replication in monocyte-derived cells, and thus provide novel insights into the underlying molecular mechanism.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCD4-Positive T-LymphocytesCell LineCullin ProteinsFluoresceinsGene Expression Regulation, ViralGene Products, vprHumansLeukocytes, MononuclearMacrophage Colony-Stimulating FactorMacrophagesSignal TransductionSimian Immunodeficiency VirusUbiquitin-Protein LigasesViral Regulatory and Accessory Proteins2,4-bis(N,N'-di(carboxymethyl)aminomethyl)fluoresceinAdaptor Proteins, Signal TransducingCUL4A protein, humanCullin ProteinsFluoresceinsGene Products, vprMacrophage Colony-Stimulating FactorUbiquitin-Protein LigasesViral Regulatory and Accessory ProteinsVPX protein, Simian immunodeficiency virus

Identifiers

PMID18464893
PMCPMC2330158
OpenAlexW2068349374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.